Developmental consequences of cryopreservation of mammalian oocytes and embryos.
During the last three decades, significant advances have been made in successful cryopreservation of mammalian preimplantation embryos, and more recently oocytes. The ability to cryopreserve, thaw, and establish pregnancies with supernumerary preimplantation embryos has become an important tool in fertility treatment. Human oocyte cryopreservation has practical application in preserving fertility for individuals at risk of compromised egg quality due to cancer treatments or advanced maternal age. While oocyte/embryo cryopreservation success has increased over time, there is still room for improvement. Oocytes and embryos are susceptible to cryo-damage, which collectively entails cellular damage caused by mechanical, chemical, or thermal forces during the freeze-thaw process. Basic studies focused on understanding cellular structures, their composition, and more importantly their functions, in normal cell developments will continue to be critical in assessing, understanding, and correcting oocyte/embryo cryo-damage. This review will delineate many of the oocyte/embryo intracellular and extracellular structures that are or may be compromised during cryopreservation. A global theme presented throughout this review is that many structural components of the oocyte/embryo also have essential functional roles in development. Compromising these cellular structures, and thus their cellular homeostatic functions, can deleteriously influence initial cryo-survival or compromise subsequent normal development through effects on the oocyte and/or early embryo.
Smith
Gary D
GD
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA. smithgd@umich.edu
Silva E Silva
Cristine Ane
CA
D000199:Actins / Q000378:metabolism; D000818:Animals; D001755:Blastocyst; D002466:Cell Nucleolus / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D015925:Cryopreservation / Q000379:methods* / Q000639:trends; D003451:Cryoprotective Agents / Q000494:pharmacology; D003593:Cytoplasm / Q000378:metabolism; D004624:Embryo Transfer; D004622:Embryo, Mammalian / Q000166:cytology*; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008854:Microscopy, Electron; D008870:Microtubules / Q000648:ultrastructure; D009685:Nuclear Envelope / Q000378:metabolism; D009865:Oocytes / Q000166:cytology*; D011247:Pregnancy; D008941:Spindle Apparatus / Q000378:metabolism; D013997:Time Factors; D015044:Zona Pellucida / Q000378:metabolism
D000199:Actins; D003451:Cryoprotective Agents